GANX Stock Analysis: Buy, Sell, or Hold?

GANX - Gain Therapeutics, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.77
-0.08 (-4.32%) ▼
5d: +1.14%
30d: +1.14%
90d: -6.35%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026

Get Alerted When GANX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: GANX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GANX is currently trading at $1.77, which is considered extended relative to its 30-day fair value range of $1.67 to $1.88.

Technical Outlook: Technically, GANX is in a downtrend. Immediate support is located at $1.56, while resistance sits at $2.05. Short-term momentum is weak, with the stock down 4.3% recently.

Market Sentiment: GANX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.20 (+306.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $1.67 - $1.88
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.3%)
  • BULLISH: Trading 306.8% below Wall St target ($7.20)

Trading Range Analysis

30-Day Trading Range $1.67 - $1.88
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $1.56
Resistance Level $2.05
Current Trend Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.95
Wall Street Target $7.20 (+306.8%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 4:25 AM ET
Data refreshes hourly during market hours. Next update: 5:25 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for GANX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$833 67 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 67 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$105 64 BUY
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 61 BUY
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 65 BUY

More Analysis for GANX

GANX Technical Chart GANX Price Prediction GANX Earnings Date GANX Investment Advisor GANX Fair Price Analyzer GANX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals